Skip to main content

Kronos Bio, Inc.

KRONDelisted Jun 20, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001741830

Kronos Bio, Inc. was delisted on Jun 20, 2025; its insiders filed their last Form 4 on Jun 20, 2025; 47 institutions reported holding it in 13F filings for Q1 2025, worth $15.8M in total; no superinvestor held it.

13F holders, Q1 2025

Institutional positions in Kronos Bio, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

KRON is no longer listed, so this page shows Q1 2025. 13F filings for later quarters list far fewer holders.

Institutional holders
47
−9 vs. Q4 2024
Shares held
19.1M
−516.9K (−2.6%) vs. Q4 2024
Total value
$15.8M
−$2.88M (−15.4%) vs. Q4 2024
New holders
4
9 more added
Sold out
13
14 more reduced

Compare with Q4 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KRON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2025: 47 institutions
Q1 2021: 71 institutionsQ2 2021: 77 institutionsQ3 2021: 83 institutionsQ4 2021: 81 institutionsQ1 2022: 96 institutionsQ2 2022: 94 institutionsQ3 2022: 96 institutionsQ4 2022: 97 institutionsQ1 2023: 87 institutionsQ2 2023: 80 institutionsQ3 2023: 63 institutionsQ4 2023: 60 institutionsQ1 2024: 58 institutionsQ2 2024: 56 institutionsQ3 2024: 53 institutionsQ4 2024: 56 institutionsQ1 2025: 47 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2025: $15.8M
Q1 2021: $1.05BQ2 2021: $956.8MQ3 2021: $811.6MQ4 2021: $557.8MQ1 2022: $282.0MQ2 2022: $134.4MQ3 2022: $120.8MQ4 2022: $55.9MQ1 2023: $47.3MQ2 2023: $54.3MQ3 2023: $39.3MQ4 2023: $33.4MQ1 2024: $28.2MQ2 2024: $25.6MQ3 2024: $19.7MQ4 2024: $18.7MQ1 2025: $15.8MQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding KRON and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 202547$15.8M
Q4 202456$18.7M
Q3 202453$19.7M
Q2 202456$25.6M
Q1 202458$28.2M
Q4 202360$33.4M
Q3 202363$39.3M
Q2 202380$54.3M
Q1 202387$47.3M
Q4 202297$55.9M
Q3 202296$120.8M
Q2 202294$134.4M
Q1 202296$282.0M
Q4 202181$557.8M
Q3 202183$811.6M
Q2 202177$956.8M
Q1 202171$1.05B

Institutions, Q1 2025

Shares, value and share of portfolio for each institution holding Kronos Bio, Inc.; share changes are against Q4 2024.

Institutions holding KRON in Q1 2025
InstitutionSharesValue% of portfolioChange in sharesAction
BNP Paribas Arbitrage, SA342$2820.00%−129−27.4%Reduced
Bank of America Corp368$3040.00%−2,854−88.6%Reduced
JPMorgan Chase & Co441$3640.00%−7−1.6%Reduced
Dakota Community Bank & Trust NA943$7780.00%00.0%Unchanged
Citigroup Inc1,078$8890.00%+1,078New
Simplex Trading, LLC2,957$2.00K0.00%+2,957New
FMR LLC4,600$3.79K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)6,079$5.01K0.00%+3,878+176.2%Added
Pathstone Holdings, LLC12,034$9.93K0.00%00.0%Unchanged
Goldman Sachs Group Inc12,238$10.1K0.00%−5,805−32.2%Reduced
HRT Financial LP13,596$11.0K0.00%+13,596New
Vestia Personal Wealth Advisors15,303$12.6K0.01%−415−2.6%Reduced
Barclays PLC16,128$13.3K0.00%00.0%Unchanged
National Bank of Canada25,000$20.6K0.00%00.0%Unchanged
GTS Securities LLC30,000$24.8K0.00%−20,000−40.0%Reduced
Jane Street Group, LLC32,071$26.5K0.00%+9,291+40.8%Added
Velan Capital Investment Management LP35,000$28.9K0.03%00.0%Unchanged
Prudential Financial Inc35,400$29.2K0.00%−20,400−36.6%Reduced
Morgan Stanley37,795$31.2K0.00%00.0%Unchanged
HSBC Holdings PLC38,368$32.6K0.00%00.0%Unchanged
Two Sigma Investments, LP55,935$46.1K0.00%−7,326−11.6%Reduced
Integrated Wealth Concepts LLC71,561$59.0K0.00%00.0%Unchanged
Samsara BioCapital, LLC78,131$64.5K0.01%00.0%Unchanged
Northern Trust Corp85,222$70.3K0.00%+10,875+14.6%Added
Squarepoint Ops LLC113,607$93.7K0.00%+15,187+15.4%Added
Bridgeway Capital Management, LLC118,927$98.1K0.00%00.0%Unchanged
Casdin Capital, LLC123,839$102.2K0.01%00.0%Unchanged
Deuterium Capital Management, LLC146,745$121.1K0.27%+146,745New
Deltec Asset Management LLC150,000$123.8K0.03%−50,000−25.0%Reduced
Susquehanna International Group, LLP155,188$128.0K0.00%+33,320+27.3%Added
State Street Corp171,225$141.3K0.00%00.0%Unchanged
GenTrust, LLC295,246$243.6K0.01%00.0%Unchanged
Woodline Partners LP306,946$253.2K0.00%−2,651−0.9%Reduced
Cerity Partners LLC410,796$338.9K0.00%00.0%Unchanged
Geode Capital Management, LLC478,208$394.6K0.00%+16,940+3.7%Added
Peapod Lane Capital LLC564,572$465.8K0.52%+1,952+0.3%Added
BlackRock, Inc.667,399$550.6K0.00%−106,877−13.8%Reduced
Siren, L.L.C.842,954$695.4K0.04%00.0%Unchanged
Renaissance Technologies LLC1,102,326$909.4K0.00%−69,482−5.9%Reduced
Acadian Asset Management LLC1,230,770$1.01M0.00%−73,741−5.7%Reduced
Wildcat Capital Management, LLC1,297,959$1.07M0.57%00.0%Unchanged
Tang Capital Management LLC1,345,413$1.11M0.06%+342,031+34.1%Added
Millennium Management LLC1,425,065$1.18M0.00%−291,436−17.0%Reduced
Alphabet Inc.1,438,232$1.19M0.08%00.0%Unchanged
Partners Capital Investment Group, LLP1,448,654$1.20M0.02%+921,154+174.6%Added
Vanguard Group Inc1,922,809$1.59M0.00%00.0%Unchanged
Vida Ventures Advisors, LLC2,765,314$2.28M16.73%00.0%Unchanged
Jacobs Levy Equity Management, Inc0$00.00%−300,968−100.0%Sold out
Choate Investment Advisors0$00.00%−274,787−100.0%Sold out
Gilead Sciences, Inc.0$00.00%−188,567−100.0%Sold out
Citadel Advisors LLC0$00.00%−186,711−100.0%Sold out
Kennedy Capital Management, Inc.0$00.00%−149,251−100.0%Sold out
Forefront Analytics, LLC0$00.00%−93,190−100.0%Sold out
Marquette Asset Management, LLC0$00.00%−80,369−100.0%Sold out
XTX Topco Ltd0$00.00%−43,117−100.0%Sold out
Engineers Gate Manager LP0$00.00%−37,684−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−14,532−100.0%Sold out
Ground Swell Capital, LLC0$00.00%−11,919−100.0%Sold out
UBS Group AG0$00.00%−2,012−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−1,663−100.0%Sold out